Illumina Total Revenue

The latest total revenue for ILMN is $4.5B as of June 2026. That compares with $4.3B in the prior-year period — up 4.9% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside Illumina's historical trend and sector peers before judging valuation or financial health.

Over the past year, ILMN's total revenue moved from $4.3B to $4.5B — a 4.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Illumina's operating scale or balance-sheet position.

Against Healthcare companies, ILMN currently prints $4.5B for total revenue, while the sector average sits near $110B. That is roughly 96.1% below the sector mean. Large gaps often invite a closer look at Illumina's growth, margins, and balance sheet.

A total revenue figure of $4.5B for ILMN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting ILMN's total revenue ($4.5B), review year-over-year change from $4.3B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.